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INTRODUCTION
Gastric antral vascular ectasia (GAVE) is a rare but import-
ant cause of gastrointestinal bleeding and anemia. Endoscopic 
ablation, such as argon plasma coagulation (APC), is usually 
successful, but treatment-refractory cases do occur (1). Recently, 
radiofrequency ablation (RFA) has been described as an alter-
native therapeutic option for GAVE, or actinic proctitis, with 
positive results and minor complications (2-5).
CASE REPORT 
A 60-year-old man with chronic renal failure in hemodialysis, 
liver cirrhosis, and chronic iron-deficiency anemia (hemoglobin 
7.5 g/dL) with transfusion requirements. GAVE was diagnosed 
after upper endoscopy, without evidence of portal hypertensive 
gastropathy (Fig. 1A). In the preceding four years his transfu-
sion requirements had increased (2 packed-red-cells monthly) 
although he underwent 17 APC sessions. An endoscopic ablation 
of antral lesions with RFA was considered.
The radiofrequency device was inserted at the gastroscope 
end. The vascular antral anomalies were treated using the 
HALO90 system (BARRX Medical, Sunnyvale, CA). In the 
first session, GAVE lesions received 31 ablations (at 12 Joules/
cm2/40 watts), twice per area, with direct and retroverted view 
(Fig. 2 A-C) for 29 minutes with good patient tolerance. A second 
session was scheduled at 4 weeks, and 68 ablations were applied 
for 36 minutes (Fig. 3 A and B). No complications were reported 
in either session.
Three months later, the majority of antral lesions had disap-
peared (Fig. 1B). Hemoglobin increased to 12 g/dL without any 
further transfusion requirement, and the patient could be included 
in a kidney transplant waiting list.
DISCUSSION
RFA is popular in the context of Barrett’s esophagus dyspla-
sia treatment. Only four published case series have reported the 
utility of RFA in GAVE lesions (2,3).
This clinical case suggests that RFA using the HALO90 
system is a real and safe option for chronic bleeding related to 
Fig. 1. Endoscopic images of the refractory gastric antral vascular ectasia 
before treatment using HALO90 system (A), and after 2 sessions of 
radiofrequency ablation (RFA) (B). Eight weeks after the last session, the 
majority of ectasia lesions have disappeared. 
refractory GAVE after attempted APC in patients with chronic 
renal failure and awaiting kidney transplantation.
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Fig. 2. First session of RFA. The radiofrequency is applied in a systematic manner (from pyloric area to proximal antrum) and turning up/down the 
HALO90 cap to assure that all the vascular ectasia lesions are treated (A, B). The mucosa that receive RFA tend to bleed and change appearance to a 
characteristic white colour (C).  
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Fig. 3. Second session of RFA. After 4 weeks following the first session, the gastric mucosa that receive RFA do not tend to bleed (A, B).
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